Jorge A. del Calvo
Pillsbury's Venture Capital practice is nationally ranked by 2013 U.S. News & World Report and Best Lawyers®.
- $10 billion in venture financing since 1999 for technology and life science startups
- Over 100 venture capital funds represented
Pillsbury counsels a wide range of high-growth enterprises and institutional investors across the U.S. and abroad. We have assisted companies from every sector at every stage of their life cycle, helping them analyze capitalization structures, develop employee incentive and stock arrangements, and evaluate financing alternatives—including venture capital opportunities and government funding sources. We blend experience in business and technology law to help clients navigate through the IPO process; establish intellectual property protection schemes; determine, assist, and negotiate the optimum distribution and strategic alliance arrangements; and advise and counsel on acquisition programs to grow or, eventually, sell the company. By counseling companies in these major decisions early on, we strive to position them for subsequent stages of growth, initial public offering, and eventual sale in areas where consolidation is likely. We also assist entrepreneurs in understanding and functioning within their regulatory environments.
We represent a number of venture capital funds and other significant institutional investors and have worked with almost all of the regional and many of the national venture capital funds. Our investor contacts are an asset in assisting the companies we represent as we facilitate business introductions when we see opportunities for collaboration. Our experience with investors—whether representing them or the companies in which they invest—helps us assist both our venture capital fund clients and our company clients in obtaining, evaluating, and structuring their financing.